Diabetes medicine reduces liver fat in nonalcoholic fatty liver disease

http://ift.tt/2FSrhhx In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH). Now a study has found that empagliflozin, a newer treatment for type 2 diabetes, reduces liver fat in patients with NAFLD and diabetes.


Fasting diets reduce important risk factor for cardiovascular disease

http://ift.tt/2DEawVu Intermittent energy restriction diets, such as the 5:2 diet, clears fat from the blood quicker after eating meals than daily calorie restriction diets – reducing an important risk factor for cardiovascular disease, a new study reports.

Mobile application detecting atrial fibrillation reduces the risk of stroke

http://ift.tt/2FTTB38 A new application developed in Finland can detect atrial fibrillation that causes strokes. Atrial fibrillation can be detected with the mobile phone application without any extra equipment. The mobile application can save lives all over the world as timely diagnosis of atrial fibrillation is crucial for effective stroke prevention.